A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Because a large proportion of patients with panic attacks receiving approved pharmacotherapy do not respond or respond poorly to medication, it is important to identify additional therapeutic strategies for the management of panic symptoms. This article describes a randomized, rater-blind study comparing low-dose risperidone to standard-of-care paroxetine for the treatment of panic attacks. METHODS: Fifty six subjects with a history of panic attacks were randomized to receive either risperidone or paroxetine. The subjects were then followed for eight weeks. Outcome measures included the Panic Disorder Severity Scale (PDSS), the Hamilton Anxiety Scale (Ham-A), the Hamilton Depression Rating Scale (Ham-D), the Sheehan Panic Anxiety Scale-Patient (SPAS-P), and the Clinical Global Impression scale (CGI). RESULTS: All subjects demonstrated a reduction in both the frequency and severity of panic attacks regardless of treatment received. Statistically significant improvements in rating scale scores for both groups were identified for the PDSS, the Ham-A, the Ham-D, and the CGI. There was no difference between treatment groups in the improvement in scores on the measures PDSS, Ham-A, Ham-D, and CGI. Post hoc tests suggest that subjects receiving risperidone may have a quicker clinical response than subjects receiving paroxetine. CONCLUSION: We can identify no difference in the efficacy of paroxetine and low-dose risperidone in the treatment of panic attacks. Low-dose risperidone appears to be tolerated equally well as paroxetine. Low-dose risperidone may be an effective treatment for anxiety disorders in which panic attacks are a significant component. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT100457106.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Reliability and validity of the Panic Disorder Severity Scale: replication and extension
Shear, M. K., Rucci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, P., & Wang, T. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00028-0 · Cited by 360
Prospective controlled study of psychiatric out-patient non-attendance: Characteristics and outcome
Killaspy, H., Banerjee, S., King, M., & Lloyd, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.2.160 · Cited by 325 · cited 1×
“As such, our study perhaps better mirrors the experience of clinicians in an office practice where patients frequently fail to return for appointments [70, 71 ].”
Melartin, T. K., Rytsala, H. J., Leskela, U. S., Lestela-Mielonen, P. S., Sokero, T. P., & Isometsa, E. T. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0207 · Cited by 260
Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197
The Relationship Between Panic Disorder and Major Depression: A New Family Study
Weissman, M. M. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820220017003 · Cited by 196 · cited 3×
“Patients with a current or lifetime history of any Axis I diagnosis other than Panic disorder or Major Depressive Disorder with Panic Attacks were excluded.”
Cigarette Smoking and Panic Psychopathology
Zvolensky, M. J., & Bernstein, A. (2005) · Current Directions in Psychological Science · doi:10.1111/j.0963-7214.2005.00386.x · Cited by 150 · cited 1×
“Lastly, we did not record tobacco use among our sample, and given the reported link between cigarette smoking and panic attacks [ 72 ], our results may be confounded by smoking in unknown ways.”
Li, X., May, R. S., Tolbert, L. C., Jackson, W. T., Flournoy, J. M., & Baxter, L. R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0610 · Cited by 110
Zvolensky, M. J., Bernstein, A., Marshall, E. C., & Feldner, M. T. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0063-6 · Cited by 73 · cited 1×
“medical disorders [ 2 ], and effective treatment for panic symptoms is important for a large number of patients.”
Perna, G., Bertani, A., Caldirola, D., Smeraldi, E., & Bellodi, L. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-14283 · Cited by 64
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics
Maher, A. R., & Theodore, G. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.s5-b.1 · Cited by 160
Albert, U., Carmassi, C., Cosci, F., De Cori, D., Di Nicola, M., Ferrari, S., Poloni, N., Tarricone, I., & Fiorillo, A. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000127 · Cited by 58
“Paroxetine was not titrated (the initial dose was 30 mg/day) and the group under paroxetine had a statistically significant higher severity of baseline depressive symptoms than those under risperidone (Prosser et al., 2009).”
Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance
Melaragno, A. J. (2021) · Focus · doi:10.1176/appi.focus.20200048 · Cited by 50
Emerging drugs for panic disorder
Perna, G., Guerriero, G., & Caldirola, D. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.628313 · Cited by 23
Metadata
- Authors
- Prosser, J. M., Yard, S., Steele, A., Cohen, L. J., & Galynker, I. I.
- Venue
- BMC Psychiatry
- Published
- 2009-05-26
- Volume
- 9
- Issue
- 1
- Pages
- 25-25
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W2163155347
- Cited by
- 32
- References
- 11
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. https://app.cochat.ai/papers/10.1186/1471-244x-9-25
- The paper
- Prosser, J. M., Yard, S., Steele, A., Cohen, L. J., & Galynker, I. I. (2009). A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-25
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.